Alexander Kirschenbaum, MD
- ASSOCIATE CLINICAL PROFESSOR | Urology
- ASSOCIATE CLINICAL PROFESSOR | Oncological Sciences
American Board of Urology
- Benign Prostatic Hyperplasia
- Bladder Cancer
- Kidney Cancer
- Prostate Cancer
MD, Mount Sinai School of Medicine
Residency, Urology, Mount Sinai Hospital
Fellowship, Urology Oncology, Mount Sinai Hospital
Kirschenbaum A, Pacheco E, Schuval BJ, Levine A. Lack of correlation between prostate-specific antigen density and prostatic shrinkage in response to finasteride therapy. World J Urol 1996; 14(6): 360-2.
Robbins SE, Shu WP, Kirschenbaum A, Levine A, Miniati DN, Liu BC. Bone extracellular matrix induces homeobox proteins independent of androgens: Possible mechanism for androgen independent growth in human prostate cancer. Prostate 1996 Dec; 29(6): 362-70.
Levine A, Wang JP, Ren M, Eliashvili E, Russell DW, Kirschenbaum A. Immunohistochemical localization of steroid 5a-reductase 2 in the human male fetal reproductive tract. J Clin Endocrinol Metab 1996 Jan; 81(1): 384-9.
Liu X, Kirschenbaum A, Yao S, Stearns ME, Holland J, Claffey K, Levine A. Upregulation of vascular endothelial growth factor by cobalt-induced hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis 1999 17(8):687-94.
Liu X, Kirschenbaum A, Yao S, Lee R, Holland J, Levine A. Inhibition of cyclooxygenase-2 suppresses angiogenesis and growth of prostate cancer in vivo. J Urol 2000 Sep; 164: 820-825.